Investigators used adeno-associated virus serotype 6 (AAV6) vectors and Cre recombination to systematically optimize the parameters for effective in vivo HSC transduction. They establishing an protocol that achieved functional recombination in over two-thirds of immunophenotypic HSCs.
[Molecular Therapy-Methods & Clinical Development]